>>Paradigm Genetics, Inc. (Nasdaq: PDGM - news) today announced the issuance of United States Patent 6,303,365, titled ``Method of determining activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5- phosphate synthase.'' The issued patent is for a gene that produces a protein that is a potential herbicide target. It was discovered jointly by Paradigm and Bayer AG through the two companies' commercial partnership.
``This patent is the first patent issued to Paradigm Genetics, and it represents the beginning of what we believe will be a very productive pipeline of valuable intellectual property resulting from our own research and our research in conjunction with our commercial partners,'' said Henry Nowak, Paradigm's General Counsel and Vice President of Intellectual Property. ``We have more than 100 patents pending, and that number grows every week.''
``Besides showing that our research is producing concrete results, this patent also demonstrates the value we bring to our commercial partners and the level of cooperation that occurs in those partnerships,'' said John A. Ryals, Ph.D., CEO and President. ``We have dedicated significant resources towards developing a comprehensive patent portfolio over the last several years, and our effort is now beginning to yield results. This is only the beginning, however. There's much more to come.''<<
snip
Cheers, Tuck |
